Shanghai Kaibao Pharmaceutical Sales Co., Ltd. announced that it will issue common share for the gross proceeds of CNY 20 million on December 10, 2021. The transaction will include participation from existing investor, Shanghai Kaibao Pharmaceutical CO.,Ltd (SZSE:300039). Post completion, the investor will retain 100% stakes in the company and registered capital of the company will increase to CNY 30 million. The transaction has been approved by first meeting of the fifth board of directors of Shanghai Kaibao Pharmaceutical CO.,Ltd (SZSE:300039) and does not need to be submitted to the general meeting of shareholders.